Indefinite Delivery Contract 36C25726D0032
- Not listed
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded Cepheid a single award indefinite delivery contract with a potential value of $1.4 million to provide COVID-19, influenza, and respiratory syncytial virus (RSV) plus SARS-CoV-2 diagnostic test kits. The contract has a last order date of April 30, 2028 and aims to procure test kits that are compatible with Cepheid instrumentation owned by the VA facility in Harlingen, Texas. Under this...
- The Department of Veterans Affairs Veterans Integrated Service Network 21 awarded a single-award, firm fixed-price Indefinite Delivery/Indefinite Quantity contract to Cepheid Inc. with a ceiling value of $700,000 and a five-year period of performance ending September 30, 2029. This contract, awarded on October 1, 2024, was established without a set-aside designation based on a sole-source determination under 41 USC 3304(a)(1) and Federal Acquisition Regulation 6.302-1, recognizing Cepheid as the...
- The Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 has awarded a single-award Indefinite Delivery Contract (IDC) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide COVID-19, influenza, and respiratory syncytial virus (RSV) testing supplies to VA medical facilities in the Dallas, Texas area. The $1,424,520.00 IDC has a period of performance through March 13, 2028, and includes a $474,840.00 delivery order for testing equipment,...
- The Department of Veterans Affairs (VA) has awarded Cepheid, a for-profit manufacturer of molecular diagnostic solutions, an Indefinite Delivery Contract (IDC) to provide reagents, test kits, and associated maintenance and support services to support the VA's clinical testing programs serving veterans. The contract, valued at up to $532,310.79, is a single-award IDC with the VA's Veterans Integrated Service Network 16 and does not have any set-aside designations. Under this IDC, the VA has...
- The Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 has awarded a Blanket Purchase Agreement (BPA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide CEPHEID REAGENTS, TEST KITS AND SUPPLIES. This single-award IDV contract has a ceiling value of $9,061,670.00 and a period of performance through September 30, 2025. The contract does not have a set-aside designation. Under this BPA, the VA has placed several task orders for Cepheid to...
- The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 awarded a single-award indefinite delivery contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to procure reagents and test kits for the VA's GeneXpert diagnostic systems. The $3,783,614.55 delivery order contract has a performance period through March 31, 2025. Cepheid, as the original equipment manufacturer, will provide the VA with the necessary diagnostic consumables to support...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded Cepheid, located in Palo Alto, California, an indefinite delivery contract with a potential value of $6,000,000 to provide Cepheid GeneXpert and GeneXpress reagents. Three firm fixed price delivery orders were subsequently awarded against this contract from 2022 through 2027, with values ranging from $409,119.60 to $933,262.29. The reagents support Cepheid's molecular diagnostic...
- The Department of Veterans Affairs (VA), Veterans Health Administration (VHA), Veterans Integrated Service Network 2 (VISN 2) awarded Cepheid, a for-profit manufacturer of molecular diagnostic solutions, a $518,924.36 firm fixed price Blanket Purchase Agreement (BPA) call contract to provide Cepheid's diagnostic testing products. The one-year contract, starting on September 11, 2023 and ending on September 10, 2024, will enable VISN 2 to continuously procure Cepheid's molecular diagnostic...
- Cepheid Inc. has been awarded a single-award Blanket Purchase Agreement by the Department of Veterans Affairs Veterans Integrated Service Network 19 (VISN 19) with a ceiling value of $6.59 million and a performance period extending from October 1, 2025, through September 30, 2027. The procurement, issued as Request for Quote #36C25925Q0594, is for molecular diagnostic testing reagents and consumables compatible with Cepheid brand analyzers, encompassing 22 line items of swabs, collection kits,...
- Cepheid Inc., a molecular diagnostic solutions manufacturer headquartered in Sunnyvale, California, was awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 20 (VISN 20) of the Department of Veterans Affairs on September 9, 2024. The contract, valued at $4.3 million with an ultimate completion date of September 8, 2029, establishes an indefinite delivery vehicle for the procurement of reagents and consumables for laboratory tests. The contract carries no...
- 36C25726D0032Indefinite Delivery Contract
- 1Federal Contract Awards
The Department of Veterans Affairs, Veterans Integrated Service Network 17, has awarded a single-award Indefinite Delivery/Indefinite Quantity contract to Cepheid Inc. (UEI: W6HQTMWB9Q28), a molecular diagnostic manufacturer based in Sunnyvale, California, with a ceiling value of $6.74 million and a performance period through December 28, 2029. This firm fixed-price contract, awarded December 22, 2025, provides respiratory and COVID-19 diagnostic reagents and test kits to support the South Texas VA Health Care System's Pathology and Laboratory Medicine Service. The primary products include GeneXpert-compatible diagnostic cartridges, specifically the XPRS4PLEX-10 for detecting influenza A, influenza B, respiratory syncytial virus, and SARS-CoV-2, and the XPRS-COV2-10 for SARS-CoV-2 detection. Cepheid was selected as the sole source vendor due to its exclusive capability to provide system-compatible cartridges meeting Clinical Laboratory Improvement Amendments, Food and Drug Administration, and College of American Pathologists compliance requirements. The contract includes ancillary services such as testing educational materials, same-day order confirmations, and next-day delivery capability, with supply delivery costs and educational materials absorbed by the vendor at no additional charge to the government. The initial task order, awarded concurrently with the indefinite delivery vehicle on December 22, 2025, carries a ceiling value of $1.56 million and a completion date of December 21, 2026, representing the first of five anticipated ordering periods. Performance will occur at Cepheid's facility in Sunnyvale, California 94089. The contract operates on a demand-driven structure with no fixed delivery schedule, allowing the government to place orders as needed through telephone requests while maintaining consistent reagent lot sequestration to ensure quality and traceability throughout the contract year. This procurement addresses critical diagnostic testing needs within the VA health system for infectious disease detection and monitoring.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 12/22/25 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36C25726D0032-36C25726N0164 | Cepheid | $1.6m | 12/22/25 | 12/21/26 | 12/19/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6550--NEW - Cepheid Reagents Contract | 36C25726Q0029 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 | Special Notice 1/1 | 10/2/25, 4:45 PM |